Search

Your search keyword '"Ivison, S"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Ivison, S" Remove constraint Author: "Ivison, S"
64 results on '"Ivison, S"'

Search Results

1. T-cell activation-induced marker assays in health and disease

2. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

7. CD34 CELL DOSE IS CORRELATED WITH HEMATOLOGIC RECOVERY BUT NOT CHRONIC GVHD: RESULTS OF THE CBMTG TRIAL COMPARING G-CSF-MOBILIZED PERIPHERAL BLOOD(G-PB) VS G-CSF STIMULATED BONE MARROW(G-BM) IN SIBLING ALLOGRAFTS FOR HEMATOLOGIC MALIGNANCIES: PH-O102

10. The phytopathogenic interaction between Claviceps purpurea and rye

15. Canada and the Commonwealth

16. Productivity Measurement and the Accountant

25. I: Background

28. Index

29. Contents

31. Notes

32. Front Matter

33. Preface

35. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

36. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

37. Improving Reliability of Immunological Assays by Defining Minimal Criteria for Cell Fitness.

38. Immune phenotyping in a pediatric multicenter transplant study: Suitability of a preformulated dry-antibody panel system.

39. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain.

40. T-cell activation-induced marker assays in health and disease.

41. Strategies for optimizing CITE-seq for human islets and other tissues.

42. Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells.

43. Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells.

44. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes.

45. Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol.

47. A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies.

48. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.

49. Plerixafor effectively mobilizes CD56 bright NK cells in blood, providing an allograft predicted to protect against GVHD.

50. Biomarker-guided stratification of autoimmune patients for biologic therapy.

Catalog

Books, media, physical & digital resources